N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2
Kyoko Nitta(Kanazawa Medical University), Daisuke Koya(Kanazawa Medical University), Takako Nagai(Tokyo Women's Medical University Hospital), Masao Toyoda(Saiseikai Nakatsu Hospital), Keizo Kanasaki(Kanazawa Medical University), Munehiro Kitada(Kanazawa Medical University), Masaru Sakurai(Kanazawa Medical University), Atsushi Nakagawa(Kure Kyosai Hospital), Masakazu Haneda(Institute for Advanced Study), Yuiko Mizunuma(Kanazawa Medical University)
Cited by 5
Related Papers
Protein Data Bank: the single global archive for 3D macromolecular structure data
|Nucleic Acids Research|2018|1.2k
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
|Journal of Clinical Investigation|1997|537
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
|The FASEB Journal|2000|427
Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy
|Proceedings of the National Academy of Sciences|1997|381